Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.

about

Green Tea Catechin-Inactivated Viral Vaccine Platform.

P2860

Q47556992-9AC6E1CD-BD18-481F-A983-43438A4CE528

P2860

Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.

Item

http://www.wikidata.org/entity/Q39007664

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immunopathogenesis associated ...... clinical and clinical studies.

@en

Immunopathogenesis associated ...... clinical and clinical studies.

@nl

type

Item

label

Immunopathogenesis associated ...... clinical and clinical studies.

@en

Immunopathogenesis associated ...... clinical and clinical studies.

@nl

prefLabel

Immunopathogenesis associated ...... clinical and clinical studies.

@en

Immunopathogenesis associated ...... clinical and clinical studies.

@nl

P1476

Immunopathogenesis associated ...... clinical and clinical studies.

@en

P2093

Abenaya Muralidharan

http://www.w3.org/2001/XMLSchema#string

Changgui Li

http://www.w3.org/2001/XMLSchema#string

Lisheng Wang

http://www.w3.org/2001/XMLSchema#string

Xuguang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments

Animal models of respiratory syncytial virus infection.

Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease.

The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.

Immune responses and disease enhancement during respiratory syncytial virus infection

Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

P304

351-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14760584.2017.1260452

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27841687

http://www.w3.org/2001/XMLSchema#string

Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.

about

P2860

P2860

Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698